Actinium Therapy for Late-stage Aggressive Sarcomas

Clinical trial NCT07156565 · RECRUITING

Trial details

NCT number: NCT07156565
Sponsor: Ratio Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Soft Tissue Sarcoma

Start date: 2025-11-12
Primary completion: 2028-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.